These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 34250317)

  • 1. Use and Safety of Remdesivir in Kidney Transplant Recipients With COVID-19.
    Buxeda A; Arias-Cabrales C; Pérez-Sáez MJ; Cacho J; Cabello Pelegrin S; Melilli E; Aladrén MJ; Galeano C; Lorenzo I; Mazuecos A; Saura IM; Franco A; Ruiz-Fuentes MDC; Sánchez-Cámara LA; Siverio O; Martin ML; González-García E; López V; Martin-Moreno PL; Moina I; Moral Berrio E; Moreso F; Portolés JM; Santana-Estupiñán R; Zárraga S; Canal C; Sánchez-Álvarez E; Pascual J; Crespo M
    Kidney Int Rep; 2021 Sep; 6(9):2305-2315. PubMed ID: 34250317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility and safety of remdesivir in SARS-CoV2 infected renal transplant recipients: A retrospective cohort from a developing nation.
    Meshram HS; Kute VB; Patel H; Banerjee S; Navadiya V; Desai S; Rizvi SJ; Mishra V; Chauhan S
    Transpl Infect Dis; 2021 Aug; 23(4):e13629. PubMed ID: 33915006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Observational Study of the Clinical Characteristics and Short-Term Outcomes of Kidney Transplant Recipients Diagnosed With COVID-19 Infection (SARS-CoV-2) Requiring Hospitalization in New Orleans.
    Giusti S; Chazin S; Vaitla P; Atiemo K; Atari M; Paramesh A; Jeon H; Torres-Ortiz A; Thimmisetty R; Garces J
    Ochsner J; 2021; 21(4):329-334. PubMed ID: 34984045
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatic Disorders With the Use of Remdesivir for Coronavirus 2019.
    Montastruc F; Thuriot S; Durrieu G
    Clin Gastroenterol Hepatol; 2020 Nov; 18(12):2835-2836. PubMed ID: 32721580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Experience With COVID-19 and Solid Organ Transplantation at a US High-volume Transplant Center.
    Yi SG; Rogers AW; Saharia A; Aoun M; Faour R; Abdelrahim M; Knight RJ; Grimes K; Bullock S; Hobeika M; McMillan R; Mobley C; Moaddab M; Huang HJ; Bhimaraj A; Ghobrial RM; Gaber AO
    Transplantation; 2020 Nov; 104(11):2208-2214. PubMed ID: 32496357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Remdesivir in People With Impaired Kidney Function Hospitalized for COVID-19 Pneumonia: A Randomized Clinical Trial.
    Sise ME; Santos JR; Goldman JD; Tuttle KR; Teixeira JP; Seibert AF; Koullias Y; Llewellyn J; Regan S; Zhao Y; Huang H; Hyland RH; Osinusi A; Winter H; Humeniuk R; Hulter HN; Gottlieb RL; Fusco DN; Birne R; Stancampiano FF; Libertin CR; Small CB; Plate M; McPhail MJ;
    Clin Infect Dis; 2024 Jun; ():. PubMed ID: 38913574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute pancreatitis as a complication of acute COVID-19 in kidney transplant recipients.
    Basic-Jukic N; Juric I; Katalinic L; Furic-Cunko V; Sesa V; Mrzljak A
    World J Clin Cases; 2024 Feb; 12(6):1104-1110. PubMed ID: 38464928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment and Outcomes of Coronavirus Disease 2019 in Kidney Transplant Recipients: A Single-center Experience.
    Bansal SB; Babras M; Rana A; Gadde A; Jha P; Jain M; Yadav D; Bansal D; Sethi S; Kher V
    Saudi J Kidney Dis Transpl; 2022 Aug; 33(Supplement):S159-S168. PubMed ID: 37675746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remdesivir: Effectiveness and Safety in Hospitalized Patients with COVID-19 (ReEs-COVID-19)-Analysis of Data from Daily Practice.
    Pantazis N; Pechlivanidou E; Antoniadou A; Akinosoglou K; Kalomenidis I; Poulakou G; Milionis H; Panagopoulos P; Marangos M; Katsarolis I; Kazakou P; Dimakopoulou V; Chaliasou AL; Rapti V; Christaki E; Liontos A; Petrakis V; Schinas G; Biros D; Rimpa MC; Touloumi G
    Microorganisms; 2023 Aug; 11(8):. PubMed ID: 37630558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of SARS-CoV-2 Subgenomic RNA in Kidney Transplant Recipients Receiving Remdesivir.
    Cuesta G; Cacho J; Cucchiari D; Herrera S; Sempere A; Akter T; Villasante A; Garrido M; Cofan F; Diekmann F; Soriano A; Marcos MA; Bodro M
    Infect Dis Ther; 2024 Jul; 13(7):1703-1713. PubMed ID: 38789902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 Infection in Kidney Transplant Recipients: A Single-Centre Study of 20 Cases from India.
    Tatapudi RR; Kopparti VR; Poosapati A; Metta S; Gongada AR; Vedulla B
    Int J Nephrol; 2021; 2021():2243095. PubMed ID: 34745662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of remdesivir in patients with COVID-19 and severe renal insufficiency: a nationwide cohort study in Japan.
    Yamada G; Ogawa Y; Iwamoto N; Suzuki M; Yamada Y; Itaya T; Hayakawa K; Ohmagari N; Yamamoto Y
    Infect Dis (Lond); 2024 Oct; ():1-10. PubMed ID: 39369333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remdesivir administration for Japanese COVID-19 patients undergoing maintenance hemodialysis: a retrospective observation with six case reports.
    Ito J; Kimura M; Toya T; Isozumi K; Kawaji A; Isozaki Y; Fukagawa M
    Ren Replace Ther; 2022; 8(1):14. PubMed ID: 35433033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential Effects of Remdesivir on Tacrolimus Exposure in Transplant Recipients With COVID-19 Infection.
    Habeeb E; Gabardi S; Townsend K; Kim M
    Kidney Int Rep; 2023 Apr; 8(7):1315-22. PubMed ID: 37360819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of remdesivir on adverse kidney outcomes in hospitalized patients with COVID-19 and impaired kidney function.
    Seethapathy R; Wang Q; Zhao S; Strohbehn IA; Long JD; Dinulos JE; Harden D; Kadiyala VB; Moreno D; Sise ME
    PLoS One; 2023; 18(2):e0279765. PubMed ID: 36848366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of disease severity and outcome of hospitalized renal transplant recipients with COVID-19 infection: a systematic review of a globally representative sample.
    Hasan I; Rashid T; Suliman S; Amer H; Chirila RM; Mai ML; Jarmi T; Khouzam S; Franco PM; Heilig CW; Wadei HM
    Rom J Intern Med; 2021 Mar; 59(1):10-42. PubMed ID: 33155999
    [No Abstract]   [Full Text] [Related]  

  • 17. Remdesivir in the Treatment of COVID-19: A Propensity Score-Matched Analysis from a Public Hospital in New York City Assessing Renal and Hepatic Safety.
    Lim H; Palaiodimos L; Berto CG; Tedunjaiye O; Malik P; Nagraj S; Choi H; Hti Lar Seng NS; Kladas M; Kharawala A; Karamanis D; Varma N; Anjali A
    J Clin Med; 2022 May; 11(11):. PubMed ID: 35683518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of safety and outcomes related to remdesivir treatment among dialysis patients hospitalized with COVID-19.
    Zaki KE; Huang CW; Zhou H; Chung J; Selevan DC; Rutkowski MP; Sim JJ
    Clin Kidney J; 2022 Nov; 15(11):2056-2062. PubMed ID: 36320364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of remdesivir in coronavirus disease 2019 (COVID-19): a systematic review.
    Roshanshad A; Kamalipour A; Ashraf MA; Roshanshad R; Jafari S; Nazemi P; Akbari M
    Iran J Microbiol; 2020 Oct; 12(5):376-387. PubMed ID: 33603991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Profiles and Outcomes of COVID-19 in Kidney Transplant Recipients: Experience From a High-Volume Public Sector Transplant Center in India.
    Kute VB; Meshram HS; Patel HV; Engineer D; Banerjee S; Navadiya VV; Patel DD; Gupta A; Chauhan S; Mishra VV
    Exp Clin Transplant; 2021 Sep; 19(9):899-909. PubMed ID: 34545775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.